Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Induction Chemotherapy With Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

NCT03427359 is registered in ClinicalTrials.gov with The University of Hong Kong-Shenzhen Hospital as lead sponsor.

NCT NCT03427359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03427359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Induction Chemotherapy With Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma
Lead sponsor
The University of Hong Kong-Shenzhen Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 22, 2015
Completion date
December 31, 2017
Enrollment
65 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma